Tracxn provides a subscription-based software platform that tracks data on private companies, startups, and investment deals for venture capital firms, investment banks, and corporate M&A teams globally.
The company possesses a narrow moat based on high switching costs and a proprietary taxonomy that organizes fragmented private market data. However, the lack of pricing power and persistent negative returns on capital suggest the moat is not yet strong enough to offset high operating costs.
Management has focused on reinvesting in data automation and sales expansion, while also initiating a share buyback in 2025 to return capital. However, these investments have yet to generate positive accounting returns, with ROCE remaining deeply negative.
The business collapsed under the weight of its own human capital costs, which consistently consumed over 85% of expenses. Despite revenue growth, the company failed to achieve true operating leverage as international demand softened and pricing power evaporated. The reliance on non-cash compensation to mask losses eventually led to massive dilution, while the proprietary taxonomy proved insufficient to stop customers from migrating to cheaper, AI-driven data aggregators that commoditized the private market data space.
RichFakir rates Tracxn Technologies Ltd's business quality as poor — 40/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Tracxn Technologies Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Tracxn Technologies Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Tracxn Technologies Ltd's fair value is about ₹8 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →